Updated on 11 Oct 2026, 11:50 PM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,756.90 | 0.25 | 4,21,529.23 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.67 | 2,47,575.99 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,660.00 | -0.32 | 1,77,245.08 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,303.30 | -0.13 | 1,05,288.19 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,115.10 | -0.01 | 1,11,231.65 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-06-18 | Issue Of Warrants |
| 2026-05-21 | Others |
| 2026-05-15 | Others |
| 2026-04-30 | Audited Results |
Sudarshan Pharma Industries is trading at 37.00 as on Fri Oct 09 2026 09:57:12. This is 5.26% upper as compared to its previous closing price of 35.15.
The market capitalization of Sudarshan Pharma Industries is 922.35 Cr as on Fri Oct 09 2026 09:57:12.
The 52 wk high for Sudarshan Pharma Industries is 42.79 whereas the 52 wk low is 18.50
Sudarshan Pharma Industries can be analyzed on the following key metrics -
Sudarshan Pharma Industries reported a net profit of 23.30 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.